New Technology for Prolonged Drug Release, 2nd Edition

A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".

Deadline for manuscript submissions: 20 October 2024 | Viewed by 2270

Special Issue Editors


E-Mail Website
Guest Editor
Department of Pharmaceutical Technology, Medical University of Białystok, Mickiewicza 2c, 15-222 Białystok, Poland
Interests: spray drying; alginates; natural polymers; microparticles; drug dosage formulations
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Pharmaceutical Technology, Medical University of Białystok, Mickiewicza 2c, 15222 Białystok, Poland
Interests: modification of delivery systems; semisolid forms; pharmaceutical analysis; drug dosage formulations
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Prolonged drug delivery systems have become the standard in drug formulation development. The most important benefits of such dosage forms include a longer duration of action, decreasing frequency of drug administration to improve patient compliance, and lower plasma concentration, which may reduce the risk of adverse effects and decrease fluctuation in plasma concentration. All these advantages promote the achievement of higher therapeutic efficacy. Innovative technologies are applicable for the increased performance of both existing and new pharmaceutical active compounds. A sustained release profile of drug substances is obtained using various technologies. One of these is the process of applying natural and synthetic polymers, which play an important role in the preparation of gelling matrixes or coating dosage forms. Another technique used to obtain a prolonged delivery system involves microencapsulation, formulating micro- or nanoparticulate systems.

This Special Issue will be a collection of full article papers and review papers focusing on recent progress in new drug delivery technologies, allowing for a sustained release profile of active substances.

Dr. Marta Szekalska
Dr. Katarzyna Sosnowska
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • prolonged drug delivery
  • sustained release
  • formulation and dosage form development
  • polymers for extended release
  • micro/nanoparticulate system
  • modification of active substances

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

12 pages, 7272 KiB  
Article
Core-Shell Microspheres Prepared Using Coaxial Electrostatic Spray for Local Chemotherapy of Solid Tumors
by Xiaowei Zhang, Rundong Zhu, Xingzhi Wang, Hao Wang, Zushun Xu, Yongan Wang, Dongqin Quan and Liao Shen
Pharmaceutics 2024, 16(1), 45; https://doi.org/10.3390/pharmaceutics16010045 - 28 Dec 2023
Viewed by 818
Abstract
Local chemotherapy is an alternative therapeutic strategy that involves direct delivery of drugs to the tumor site. This approach avoids adverse reactions caused by the systemic distribution of drugs and enhances the tumor-suppressing effect by concentrating the drugs at the tumor site. Drug-loaded [...] Read more.
Local chemotherapy is an alternative therapeutic strategy that involves direct delivery of drugs to the tumor site. This approach avoids adverse reactions caused by the systemic distribution of drugs and enhances the tumor-suppressing effect by concentrating the drugs at the tumor site. Drug-loaded microspheres are injectable sustained-release drug carriers that are highly suitable for local chemotherapy. However, a complex preparation process is one of the main technical difficulties limiting the development of microsphere formulations. In this study, core-shell structured microspheres loaded with paclitaxel (PTX; with a core-shell structure, calcium alginate outer layer, and a poly (lactic acid-co-glycolic acid) copolymer inner layer, denoted as PTX-CA/PLGA-MS) were prepared using coaxial electrostatic spray technology and evaluated in vitro and in vivo. PTX-CA/PLGA-MS exhibited a two-stage drug release profile and enhanced anti-tumor effect in animal tumor models. Importantly, the preparation method reported in this study is simple and reduces the amount of organic solvent(s) used substantially. Full article
(This article belongs to the Special Issue New Technology for Prolonged Drug Release, 2nd Edition)
Show Figures

Figure 1

30 pages, 7651 KiB  
Article
Mucoadhesive Alginate/Pectin Films Crosslinked by Calcium Carbonate as Carriers of a Model Antifungal Drug—Posaconazole
by Marta Szekalska, Anna Czajkowska-Kośnik, Bartosz Maciejewski, Iwona Misztalewska-Turkowicz, Agnieszka Zofia Wilczewska, Jurga Bernatoniene and Katarzyna Winnicka
Pharmaceutics 2023, 15(10), 2415; https://doi.org/10.3390/pharmaceutics15102415 - 03 Oct 2023
Viewed by 1030
Abstract
The mucosal membrane of the oral cavity, due to its unique structure and availability, constitutes an appropriate site for the delivery of drugs, both with local and systemic effects. Mucoadhesive buccal films are drug dosage forms that due to their convenience of application, [...] Read more.
The mucosal membrane of the oral cavity, due to its unique structure and availability, constitutes an appropriate site for the delivery of drugs, both with local and systemic effects. Mucoadhesive buccal films are drug dosage forms that due to their convenience of application, flexibility and size, are characterized by patients’ compliance. Sodium alginate and pectin are natural polymers from the polysaccharides group, with mucoadhesive properties, that are widely applied to obtain buccal films. However, their hydrophilic nature and poor water resistance limit their application in sustained drug release formulations. Hence, the aim of this investigation was to design alginate/pectin buccal films by a one-step crosslinking technique—with the application of calcium carbonate. This technique was applied to prepare crosslinked alginate and alginate/pectin mucoadhesive films with a model antifungal drug—posaconazole. The obtained formulations were evaluated for the impact of crosslinking and pectin’s presence on their pharmaceutical, mucoadhesive, mechanical and physicochemical properties. Additionally, the antifungal activity of the prepared films against Candida spp. was evaluated. It was shown that pectin’s presence in the formulations improved flexibility, mucoadhesion and antifungal activity. The crosslinking process reduced mucoadhesiveness and antifungal activity but significantly enhanced the mechanical properties and stability and enabled prolonged drug release. Full article
(This article belongs to the Special Issue New Technology for Prolonged Drug Release, 2nd Edition)
Show Figures

Graphical abstract

Back to TopTop